SoCalBio Mast
SoCalBio Weekly Update
Past Weekly Updates

Make a Donatation to Support the SoCalBio Weekly Update

Cut the Cost of Doing Business
 
 
 Utilize AT Conference for Phone and Web Conferencing
 
SoCalBio's Group Purchasing Committee is pleased to announce that AT Conference was selected to provide member companies with phone and web conferencing services at significant discounts. Click to see benefits and enroll (must be a SoCalBio member company or organization)
 
Great Savings - SoCalBio Special Rate of 5¢/minute
Join SoCalBio
 
Join well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
Become a Member
Looking for Experts to Help You Devise PR, Communicatons and Branding Strategies?
 
Lab Equipment for Sale
 
Click here for a list of lab equipment available for sale by NeuroGeneration (Los Angeles)
Available for Lease
Wet Lab Space
House Ear Institute (Los Angeles) offers several thousand square feet of laboratory and laboratory support space for short to medium-term lease at competitive rents. This is ideal for startups and early-stage companies. Learn more
Biotech Demystified
The Science Behind the Business
June 8-10, 2009
 
Rady Center for Executive Development, UC San Diego
San Diego, CA 
 
  
Fee: $3,700 with hotel, $2,950 without hotel
Momentum Weekend for Women in Life Sciences
 
June 11-14 2009
 Keck Graduate Institute
 
Learn more
Recommended Events
 
MDMA Annual Meeting
June 1 - 3 
 
------------------------------ --------
 
 
More Information
------------------------------ -----------------

Register Now

Forward to a Friend

 May 18, 2009

Visit the Southern California Biomedical Council at the California Life Science Industry Alliance's Booth at the May 18 - 21, 2009 BIO International Convention in Atlanta, GA (Booth Number: 4033 - California Pavilion)

Coming This Fall
Thanks to Lead SoCalBio Sponsor
  

RSVP Now for SoCalBio Events
Biotech Finance

E&Y Report Says Money Getting Tighter For Small Biotechs

A new report from Ernst & Young says that more than four in 10 biotechs have less than one year of cash on hand. Only a handful of biotechs are profitable. The rest need financing to see them through to commercialization. These days, they have to be innovators -- not only in science, but also in fundraising, says Scott Morrison, U.S. life sciences director for Ernst & Young.... Read more
M&As
The Irvine-Based IDM Pharma to Be Bought by Takeda Pharmaceutical Co. for $2.64-share
 
IDM, the developer of anti-cancer drugs, agreed to be bought for over $68 million. The companies hope to close the deal by July 22. Read more

Beckman Coulter Gets Antitrust OK for Buyout 

The Fullerton-based Beckman received antitrust clearance from the Federal Trade Commission for its plan to buy Olympus Corp.'s lab-based diagnostics business for about $780 million .... Read more
Product Approvals

The Sylmar-Based Cardiac Rhythem Management Division of St. Jude Medical Gets EU OK for Two Wireless Telemetry Cardiac Pacers

The Accent and Anthem product family features RF telemetry that enables secure, wireless communication between the implanted device and the programmer used by the clinician, making it the first integrated system of pacing devices with wireless telemetry from implant through follow-up. Wireless communication is used when clinicians implant the device and during follow-up appointments, which can be performed in the office or via remote monitoring with the patient at home, allowing for more efficient and convenient care and device management... Read more
Stem Cell Banking

Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory 

"Having our own secure cryogenic stem cell bank will provide Cord Blood America (Santa Monica) with tremendous growth potential not only with our existing cord blood processing and storage business but also emerging sciences for other types of stem cells, including peripheral blood stem cell and adipose tissues," Said CEO Mr. Schissler ... Read more
Supply Agreement

Osmetech Molecular Diagnostics of Pasadena Chosen as Principal Supplier for a Major Clinical Trial

The company signed an agreement as principal supplier of Warfarin Sensitivity tests for a major new US trial sponsored by the US National Heart, Lung, and Blood Institute (NHLBI) part of the National Institutes of Health (NIH) in the US. Investigators for the upcoming Clarification of Optimal Anticoagulation through Genetics Trial (COAG Trial) have selected Osmetech's Warfarin Sensitivity Tests and eSensor XT-8 molecular diagnostics instrument platform for ten of the twelve sites identified to run the trial. The University of Pennsylvania is the Coordinating Center for the trial.... Read more
Clinical Studies

The Irvine-Based Edwards Lifesciences Announces First Human Implants With 18 French Transcatheter Valve System

 "The clinical success of the Edwards SAPIEN valve has allowed us to treat patients who previously had no good treatment options. The new Edwards SAPIEN XT valve, with its improved design and revolutionary lower profile delivery system, will allow us to treat aortic stenosis patients even more reliably and safely," said John Webb, M.D., who performed the first successful human implants of the new transcatheter system. Webb is director of the cath lab and cardiac intervention at St. Paul's Hospital in Vancouver, British Columbia, and a consultant to Edwards Lifesciences... Read more
 
Xencor (Monrovia, CA) to Present Phase 1 Data on XmAb2513 Antibody for Lymphomas at the American Society of Clinical Oncology Annual Meeting in June
 
 XmAb2513 is a humanized monoclonal antibody that targets the antigen CD30, a molecule expressed on the surface of a number of tumor cell types. XmAb2513 has been engineered to contain an XmAb Fc domain to greatly increase its cytotoxic potency. XmAb2513 shows superior activity in recruiting primary human immune cells to kill tumor cells in in vitro models and is active in blocking tumor growth in rodent models..... Read more
Jobs

About SoCalBio
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio 
 
Editor: Ahmed A. Enany
Southern California Biomedical Council (SoCalBio)